Yoshikazu Mutoh
About
In The Last Decade
Yoshikazu Mutoh
16 papers receiving 57 citations
Peers
Comparison fields: 5 of 35
- Infectious Diseases 29
- Epidemiology 21
- Endocrinology 10
- Molecular Medicine 7
- Pharmacology 6
Countries citing papers authored by Yoshikazu Mutoh
This map shows the geographic impact of Yoshikazu Mutoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshikazu Mutoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshikazu Mutoh more than expected).
Fields of papers citing papers by Yoshikazu Mutoh
This network shows the impact of papers produced by Yoshikazu Mutoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshikazu Mutoh. The network helps show where Yoshikazu Mutoh may publish in the future.
Co-authorship network of co-authors of Yoshikazu Mutoh
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshikazu Mutoh. A scholar is included among the top collaborators of Yoshikazu Mutoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshikazu Mutoh. Yoshikazu Mutoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 4 | |
| 16 | 7 | |
| 17 | 8 | |
| 18 | 5 | |
| 19 | 4 | |
| 20 | [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.